Advanced Search

Refine my results

Document type

Institution

Specific Collection

Language

Author

Domain

Keyword

Sorted by: Date of deposit
5 results 1
Postprint
Consortium of Swiss Academic Libraries

Symptoms of endocrine treatment and outcome in the BIG 1-98 study

Huober, J. ; Cole, B. ; Rabaglio, M. ; Giobbie-Hurder, A. ; Wu, J. ; Ejlertsen, B. ; Bonnefoi, H. ; Forbes, J. ; Neven, P. ; Láng, I. ; Smith, I. ; Wardley, A. ; Price, K. ; Goldhirsch, A. ; Coates, A. ; Colleoni, M. ; Gelber, R. ; Thürlimann, B.

In: Breast Cancer Research and Treatment, 2014, vol. 143, no. 1, p. 159-169

Postprint
Consortium of Swiss Academic Libraries

Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07)

Zaman, K. ; Thürlimann, B. ; Huober, J. ; Schönenberger, A. ; Pagani, O. ; Lüthi, J. ; Simcock, M. ; Giobbie-Hurder, A. ; Berthod, G. ; Genton, C. ; Brauchli, P. ; Aebi, S.

In: Annals of Oncology, 2012, vol. 23, no. 6, p. 1474-1481

Postprint
Consortium of Swiss Academic Libraries

Pegfilgrastim ± ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study

von Minckwitz, G. ; Kümmel, S. ; du Bois, A. ; Eiermann, W. ; Eidtmann, H. ; Gerber, B. ; Hilfrich, J. ; Huober, J. ; Costa, S. D. ; Jackisch, C. ; Grasshoff, S.-T ; Vescia, S. ; Skacel, T. ; Loibl, S. ; Mehta, K. M. ; Kaufmann, M.

In: Annals of Oncology, 2007, vol. 19, no. 2, p. 292-298

Postprint
Consortium of Swiss Academic Libraries

Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)†

Gerber, B. ; Loibl, S. ; Eidtmann, H. ; Rezai, M. ; Fasching, P. A. ; Tesch, H. ; Eggemann, H. ; Schrader, I. ; Kittel, K. ; Hanusch, C. ; Kreienberg, R. ; Solbach, C. ; Jackisch, C. ; Kunz, G. ; Blohmer, J. U. ; Huober, J. ; Hauschild, M. ; Nekljudova, V. ; Untch, M. ; von Minckwitz, G.

In: Annals of Oncology, 2013, vol. 24, no. 12, p. 2978-2984

Postprint
Consortium of Swiss Academic Libraries

Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)

Rochlitz, C. ; Ruhstaller, T. ; Lerch, S. ; Spirig, C. ; Huober, J. ; Suter, T. ; Bühlmann, M. ; Fehr, M. ; Schönenberger, A. ; von Moos, R. ; Winterhalder, R. ; Rauch, D. ; Müller, A. ; Mannhart-Harms, M. ; Herrmann, R. ; Cliffe, B. ; Mayer, M. ; Zaman, K.

In: Annals of Oncology, 2011, vol. 22, no. 1, p. 80-85

5 results 1